e-Drug3D

789

EPTIFIBATIDE


INN
EPTIFIBATIDE

cas 148031-34-9
CLASS

BLOOD
ANTICOAGULANTS
ANTIPLATELET AGENTS
PLATELET AGGREGATION INHIBITORS

ROUTE (list)

INJECTION

ATC code

B01AC16

PK parameters

VD 11.05 LITER (65 KILOGRAM)
Cl 4.6 LITER / HOUR (65 KILOGRAM)
PPB 25 PERCENT
t1/2 4.2 HOUR

Target

TARGET PLATELET RECEPTOR GLYCOPROTEIN IIB/IIIA

DrugCentral

Integrin alpha-IIb,beta-3 UNIPROT P05106 ITGB3

Download SDF file 2-[20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid

Formula:
C35H49N11O9S2

Calculated chemical properties:

MW 830.98
NB_atoms 57
XLogP -3.39
PSA 291.611
NB_HD 12
NB_HA 20
fsp3 0.51
Lipinski(0=no;1=yes) 0

FDA
NDA 020718 (label) INN (EPTIFIBATIDE) INTEGRILIN (MSD SUB MERCK) APPROVAL= AP YEAR= 1998 DISCONTINUED
NDA 090854 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2015
NDA 091555 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2015 DISCONTINUED
NDA 206127 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (EUGIA PHARMA) APPROVAL= AP YEAR= 2015
NDA 205581 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE () APPROVAL= AP YEAR= 2016 DISCONTINUED
NDA 204589 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (RISING) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 205557 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 204693 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2018
NDA 203258 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (MYLAN LABS LTD) APPROVAL= AP YEAR= 2018
NDA 208554 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2018
NDA 204361 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (USV) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 204362 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (USV) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 209864 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (SLATE RUN PHARMA) APPROVAL= AP YEAR= 2019
NDA 207864 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (HYBIO) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 213081 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (SHUANGCHENG) APPROVAL= AP YEAR= 2021
NDA 213599 (pdf not found) INN (EPTIFIBATIDE) EPTIFIBATIDE (MEITHEAL) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL